NCT05170243View on ClinicalTrials.gov

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 21, 2022

Primary Completion Date

July 3, 2022

Study Completion Date

October 28, 2022

Conditions
AsthmaCOPDAtopic Dermatitis
Interventions
DRUG

9MW1911 Injection

Single dose intravenously on day 1

DRUG

9MW1911 Injection Placebo

Single dose of matching placebo intravenously on day 1

Trial Locations (1)

200540

Shanghai Public Health Center, Shanghai

All Listed Sponsors
lead

Mabwell (Shanghai) Bioscience Co., Ltd.

INDUSTRY